Company profile
Oncomatryx Biopharma
- Industry
- Pharmaceutical Manufacturing
- Employees
- 38
- Headquarters
- Derio, Bizkaia
- Founded
- 2009
- LinkedIn followers
- 6,484
- Office locations
- 1
Oncomatryx Biopharma company summary
Oncomatryx Biopharma is a company in the Pharmaceutical Manufacturing industry, headquartered in Derio, Bizkaia, founded in 2009. On LinkedIn the company has around 38 employees and 6,484 followers. Its listed specialties include Tumor microenvironment, Stroma, Antibody Drug Conjugate (ADCs), Precision drugs, Pancreatic cancer.
What technology does Oncomatryx Biopharma use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Oncomatryx Biopharma
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment. Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma. Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumor invasiveness, drug resistance and immunosuppression. Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy.
Specialties
Where is Oncomatryx Biopharma located?
Oncomatryx Biopharma lists 1 location.
Compare companies similar to Oncomatryx Biopharma
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Oncomatryx Biopharma oncomatryx.com | Pharmaceutical Manufacturing | 38 | 2009 | Derio, Bizkaia |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Oncomatryx Biopharma
What does Oncomatryx Biopharma do?
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment. Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma. Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumor invasiveness, drug resistance and immunosuppression. Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy.
How many employees does Oncomatryx Biopharma have?
Oncomatryx Biopharma has around 38 employees on LinkedIn.
Where is Oncomatryx Biopharma headquartered?
Oncomatryx Biopharma is headquartered in Derio, Bizkaia.
When was Oncomatryx Biopharma founded?
Oncomatryx Biopharma was founded in 2009.
Build a lead list from companies like Oncomatryx Biopharma
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.